Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.

The updatedannual Fortune 500 list ranking the largest public companies by revenue was released Monday. Fortune said the 500 ...

The domestic pharmaceutical sector expects sales to grow 8-10% in the financial year 2023-24, indicated an analysis done by CRISIL, a global analytical research and rating agency. Indian pharma ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the branded pharmaceuticals stocks, including Pfizer ...

Tobacco-funded research is still appearing in highly-cited medical journals - despite attempts by some to cut ties altogether ...

Pharmaceutical manufacturer Sigachi Industries has announced a 10 per cent final dividend for FY25 after posting a strong Q4 ...

Two of Ace investor and one of India’s Warren Buffett, Madhusudan Kela’s favourite stocks now trade at discounts of over 50%.

Despite the long holiday weekend, news in biopharma never slows down. | This week on "The Top Line," we break down ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

Critical voices on unfairly high mpox and other vaccine prices open the debate on the ‘right price’ to be paid to private vaccine suppliers. We apply compound real options analysis as a more ...

Seven pharmaceutical giants with a presence in New Jersey have announced billions in expansions. The timing is no surprise, health care analysts say.

From mRNA breakthroughs to cloud-based analytics, sector specialists outline the technological innovations and skills ...